The use of tacrine for tardive dyskinesia

Abstract
The authors administered 45-90 mg/day of tacrine to eight patients with tardive dyskinesia. After 2 weeks of treatment, there was a mean reduction in tardive dyskinesia scores of 43%. No improvement occurred when a placebo was used instead of tacrine.

This publication has 0 references indexed in Scilit: